Trivium Point Advisory’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Trivium Point Advisory’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$4K	–	174
2019 Q3	$4K	Buy	+10,000	New	+$5.57K	﹤0.01%	159

Trivium Point Advisory's CELGZ Position: Q4 2019 in Review

Trivium Point Advisory sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 10,000 shares — an estimated $4K sold.

Trivium Point Advisory first reported a position in CELGZ in Q3 2019 and held it in 1 quarter. The position peaked at $4K in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

Trivium Point Advisory reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
Trivium Point Advisory sold 10,000 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $4K.
Trivium Point Advisory first reported a position in Celgene Corporation Contingent Value Rights in Q3 2019 and held it in 1 quarter.
Trivium Point Advisory's Celgene Corporation Contingent Value Rights position peaked at $4K in Q3 2019.
0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Trivium Point Advisory's 13F filing for Q4 2019, filed 29 Jan 2020.